Safety and Efficacy of OC-1 Therapy in Patients With R/R T-ALL/LL

Clinical trial NCT05679895 · RECRUITING

Trial details

NCT number: NCT05679895
Sponsor: OneChain Immunotherapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

T-cell Acute Lymphoblastic Leukemia Lymphoblastic T-Cell Lymphoma

Start date: 2023-01-31
Primary completion: 2027-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.